Medicinova IncMNOV

NasdaqHealthcarePharmaceutical Preparations
Price (close)
$2.65
Market cap
$130.4M
P/E
—
Revenue (TTM)
$920,481
Net income
-$10.8M
Dividend yield
—
1-year total return
113.7%
Net margin
-1168.2%
Revenue growth
—
Debt / equity
—

What Medicinova Inc does.

No business description on file yet.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue—$4.0M—$1.0M—$409,657
Net income-$13.9M-$10.1M-$14.1M-$8.6M-$11.0M-$12.0M
Free cash flow-$10.9M-$9.4M-$12.9M-$7.5M-$10.6M-$9.8M

More on MNOV.

Figures from Medicinova Inc's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.